4Bases

Manno, Switzerland

Molecular Diagnostics Diagnostics Cancer Genetic Disorders

4Bases is a Swiss biotechnology firm founded in 2013, specializing in the development and production of clinically validated molecular diagnostic kits for genetic testing. Focusing primarily on oncology and cardiovascular diseases, they offer CE-IVD certified solutions utilizing Next Generation Sequencing (NGS) technologies. Their portfolio includes reagent kits, data analysis software such as 4eVAR and KaryoSolver, and diagnostic protocols designed specifically for healthcare professionals. Committed to precision and quality, the company holds ISO 13485 certification to facilitate accurate genomic profiling and support effective disease diagnosis and management within clinical settings.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out 4Bases on @MedStartr Today #GeneticDisorders #CancerDiagnosis #CancerGenomics #MolecularDiagnostics #Diagnostics #Cancer #MedMo #MedStartrVentures

https://www.medstartr.ai/s/xDAdYSdSbBM

Get Involved in 4Bases

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2013
Website: 4bases.ch/

Disease Areas

Genetic Disorders Cancer Diagnosis Cancer Genomics

Technologies

Molecular DiagnosticsGenetic TestingIn Vitro DiagnosticsGenomics

🌐Website

What do you think of 4Bases?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.